We have achieved important milestones
with our ESG standards

We shape all our actions based on our ESG (Environmental, Social, Governance) standards. During 2019 and 2020, we achieved important milestones within this framework.

ENVIRONMENTAL

The only pharma company in Türkiye that reports to and is audited by Carbon Disclosure Project (CDP)

The only signatory company in Türkiye for the Science Based Targets Initiative (SBTi)

The only Turkish pharma company to sign the CEO Water Mandate, a UNGC initiative

The first company* that healthcare workers name when asked about “the most sustainable pharma company”

Signatory to the We Mean Business Coalition

Pharmaceutical company having acquired the Green Office Certificate for its Headquarters building by completing the Green Office Program of WWF-Türkiye


* Based on a study conducted by ERA Research & Consultancy

CARBON FOOTPRINT

%100
First Turkish pharma company to switch to 100% renewable electricity

0
Scope 2 carbon emissions

↓%53
Carbon footprint reduction in 2020

↓%45
Scope 1* carbon emissions reduction in 2020

* Emissions associated with electricity, natural gas, coolants used in air conditioners and energy used for heating buildings.

Scope 1
Direct greenhouse emissions
Scope 2
Indirect greenhouse emissions that occur at the facility where they are generated (associated with the purchase of electricity, heat, or cooling)

NET-ZERO CARBON PROMISE

Abdi İbrahim’s goal to become carbon neutral by 2030

7,123 kg of paper savings
Total amount of paper saved in 2019 and 2020

391 m³ of water savings
Total amount of water saved in 2019 and 2020

SOCIAL

HOLISTIC HEALTH

The widest product portfolio in the industry, offering over 200 brands and 400 products

More than 30 licensers

Leading position in the market with more than 128 therapeutic areas

Contribution to localization of the industry

Addition of 15 million healthy years of life over the course of the next 20 years

Quick production of medications that entered the treatment protocol for COVID-19

LOCAL COMMITMENT

Support for local initiatives with our Social Innovation Program

Projects to create awareness on health and the environment with our Corporate Volunteering Program

Main sponsor of national swimmers Emre Sakcı and Merve Tuncel

Awareness work on the importance of physical and mental health in society

Creating scientific awareness in youth

THE AREAS OF FOCUS IN SOCIAL INVESTMENT PROGRAMS

Health and Sports

Science

Innovation

Volunteering

TRAINING

40.1 hours
Average training per person in 2020: 40.1 hours

DIVERSITY AND INCLUSION

31% Women, 69% Men

20%
Rate of Women in the Leadership Team

55%
Rate of Women in the Headquarters

62%
Rate of Women in the R&D Center

ADMINISTRATIVE

ECONOMIC DEVELOPMENT

In 2020:

645 million dollars'
worth of added value

Direct or indirect employment of
20.000 people

70 million dollars
of direct foreign investment

100 million dollars’ worth of exports to more than
60 countries

80 million dollars of savings
in the public health budget thanks to Abdi Ibrahim’s production of the first biosimilar in oncology and three first generics

AMBITIOUS INNOVATION

45 digital initiatives as part of the corporate digital transformation program

Employment of
128 scientists in the R&D department

Investments in OM Pharma in Switzerland andOcugen in the US

‍Regional and national leadership in biotechnology with its AbdiBio facility, where all processes, starting from the cell line to the final product, are produced

Investment in İnoliva, a consumer health company

Number of platforms and initiatives supported and joined:34

Reducing foreign dependency with its capacity to manufacture mRNA and inactivated vaccines

Number of violations of the Pharmaceutical Advertising Laws and Regulations:0

In 2019 and 2020, the Esenyurt Production Complex was audited by 29 health authorities and customers, passing all inspections.